{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:18:24Z","timestamp":1763036304704,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.rdc.2007.11.004","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T14:37:26Z","timestamp":1205332646000},"page":"239-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Systemic Sclerosis and Localized Scleroderma in Childhood"],"prefix":"10.1016","volume":"34","author":[{"given":"Francesco","family":"Zulian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2007.11.004_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.22551","article-title":"The PRES\/ACR\/EULAR provisional classification criteria for juvenile systemic sclerosis","volume":"57","author":"Zulian","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib3","first-page":"1004","article-title":"Childhood-onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult-onset disease","volume":"33","author":"Scalapino","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib4","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1002\/art.22207","article-title":"Systemic sclerosis in childhood: clinical and immunological features of 153 patients in an international database","volume":"54","author":"Martini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.60.6.585","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres","volume":"60","author":"Della Rossa","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"SII","key":"10.1016\/j.rdc.2007.11.004_bib6","first-page":"213","article-title":"EULAR\/EUSTAR recommendations for the treatment of systemic sclerosis (SSc)","volume":"66","author":"Kowal-Bielecka","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.004_bib7","unstructured":"Zulian F, Kowal-Bielecka O, Miniati I, et al. Preliminary agreement of the Pediatric Rheumatology European Society (PRES) on the EUSTAR\/EULAR recommendations for the management of systemic sclerosis in children [abstract]. Proceedings of the 14th Pediatric Rheumatology Congress. Istanbul (Turkey), September 5\u20139, 2007."},{"key":"10.1016\/j.rdc.2007.11.004_bib8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","article-title":"Calcium channel blockers for Raynaud's phenomenon in systemic sclerosis","volume":"44","author":"Thompson","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2007.11.004_bib9","article-title":"Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis","author":"Pope","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.rdc.2007.11.004_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/rheumatology\/keg480","article-title":"Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases","volume":"43","author":"Zulian","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2007.11.004_bib11","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2007.11.004_bib12","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","article-title":"A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma","volume":"54","author":"Hoyles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","article-title":"Randomized unblinded trial of cyclophosphamide (CYC) versus azathioprine (AZ) in the treatment of systemic sclerosis","volume":"25","author":"Nadashkevich","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case\u2013control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib15","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.10589","article-title":"Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial","volume":"46","author":"DeMarco","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","article-title":"A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma","volume":"44","author":"Pope","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med"},{"issue":"1 Suppl 40","key":"10.1016\/j.rdc.2007.11.004_bib18","first-page":"S57","article-title":"Clinical features and outcome in juvenile systemic sclerosis (JSSc): data from the international Padua database of 153 patients","volume":"24","author":"Martini","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","article-title":"Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival","volume":"81","author":"Scussel-Lonzetti","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.rdc.2007.11.004_bib20","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2007.11.004_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpeds.2006.04.052","article-title":"Congenital localized scleroderma","volume":"149","author":"Zulian","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.rdc.2007.11.004_bib23","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Subspecialty clinics: rheumatology and dermatology. Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2007.11.004_bib24","unstructured":"Zulian F, Ruperto N. Proceedings of the II Workshop on Juvenile Scleroderma Syndrome. Padua (Italy), June 3\u20136, 2004."},{"key":"10.1016\/j.rdc.2007.11.004_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1468-3083.2005.00979.x","article-title":"Long-lasting follow-up favours a close relationship between progressive facial hemiatrophy and scleroderma en coup de sabre","volume":"19","author":"Jablonska","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.rdc.2007.11.004_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1525-1470.1997.tb00216.x","article-title":"Neurologic abnormalities in two patients with facial hemiathrophy and sclerosis coexisting with morphea","volume":"14","author":"Menni","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4615-4857-7_14","article-title":"Linear scleroderma en coup de sabre: relationship with progressive facial hemiatrophy","volume":"455","author":"Blaszczyk","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rdc.2007.11.004_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaad.2005.10.020","article-title":"Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients","volume":"54","author":"Sommer","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1525-1470.2002.00033.x","article-title":"Squamous cell carcinoma in pansclerotic morphea of childhood","volume":"19","author":"Wollina","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1365-2133.2001.04041.x","article-title":"Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea","volume":"144","author":"Parodi","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib31","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.jaad.2004.10.881","article-title":"Disabling pansclerotic morphea: clinical presentation in two adults","volume":"53","author":"Maragh","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib32","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2007.11.004_bib33","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib34","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1528-1157.2001.45800.x","article-title":"Neuropathological findings in a patient with epilepsy and the Parry-Romberg syndrome","volume":"42","author":"DeFelipe","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.rdc.2007.11.004_bib35","first-page":"193","article-title":"Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship?","volume":"30","author":"Flores-Alvarado","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1542\/peds.2005-0470","article-title":"Linear scleroderma en coup de sabre with associated neurologic abnormalities","volume":"117","author":"Holland","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2007.11.004_bib37","first-page":"2692","article-title":"Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease","volume":"27","author":"Weber","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib38","first-page":"786","article-title":"Esophageal involvement in juvenile localized scleroderma","volume":"25","author":"Guariso","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disease","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2007.11.004_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0190-9622(86)70217-X","article-title":"Anticentromere antibody in localized scleroderma","volume":"15","author":"Ruffatti","year":"1986","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2230.2005.01776.x","article-title":"Rheumatoid factor isotypes in localized scleroderma","volume":"30","author":"Mimura","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/art.11432","article-title":"Anti-DNA topoisomerase II\u03b1 autoantibodies in localised scleroderma","volume":"50","author":"Hayakawa","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2249.1998.00747.x","article-title":"Mapping of topoisomerase II\u03b1 epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis","volume":"114","author":"Grigolo","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2007.11.004_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/ard.62.8.771","article-title":"Antiphospholipid antibody in localised scleroderma","volume":"62","author":"Sato","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2007.11.004_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0038-1648840","article-title":"Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects","volume":"72","author":"Vila","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rdc.2007.11.004_bib46","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/41.10.1178","article-title":"Juvenile-onset localized scleroderma activity detection by infrared thermography","volume":"41","author":"Martini","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2007.11.004_bib47","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1002\/art.22920","article-title":"Laser Doppler flowmetry for assessing localized scleroderma in children","volume":"56","author":"Wiebel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2007.11.004_bib48","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kel446","article-title":"A new computerized method for the assessment of skin lesions in localized scleroderma","volume":"46","author":"Zulian","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2007.11.004_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02012193","article-title":"Localized scleroderma: imaging features","volume":"24","author":"Liu","year":"1994","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.rdc.2007.11.004_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","volume":"39","author":"Cunningham","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","article-title":"First case series on the use of imiquimod for morphoea","volume":"153","author":"Dytoc","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4615-4857-7_44","article-title":"Treatment of generalized morphea with oral 1,25-dihydroxyvitamin D3","volume":"455","author":"Caca-Biljanovska","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rdc.2007.11.004_bib53","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","article-title":"Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized scleroderma and systemic scleroderma","volume":"43","author":"Hulshof","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low dose UVA phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea","volume":"18","author":"Kreuter","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-0781.2001.170401.x","article-title":"Effects of low dose ultraviolet A-1 phototherapy on morphea","volume":"17","author":"Gurss","year":"2001","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.rdc.2007.11.004_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1067\/mjd.2000.109307","article-title":"Photochemotherapy for systemic and localized scleroderma","volume":"43","author":"De Rie","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0781.2004.00080.x","article-title":"Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study","volume":"20","author":"El-Mofty","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.rdc.2007.11.004_bib59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/1523-1747.ep12522855","article-title":"The carcinogenic effect of UVA irradiation","volume":"81","author":"Staberg","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib61","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1073\/pnas.90.14.6666","article-title":"Wavelengths effective in induction of malignant melanoma","volume":"90","author":"Setlow","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2007.11.004_bib62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","article-title":"Low-dose methotrexate in the treatment of widespread morphea","volume":"39","author":"Seyger","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.rdc.2007.11.004_bib64","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archderm.141.7.847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma","volume":"141","author":"Kreuter","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib65","first-page":"609","article-title":"Treatment of pediatric localized scleroderma with methotrexate","volume":"33","author":"Fitch","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2007.11.004_bib66","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X07000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X07000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:08:40Z","timestamp":1760180920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X07000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0889857X07000968"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2007.11.004","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Sclerosis and Localized Scleroderma in Childhood","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2007.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}